Dysfunction of IL-10-producing type 1 regulatory T cells and CD4+CD25+ regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys

International Immunopharmacology

Volumn 9, Issue 5, 2009, Pages 599-608

  Ma, Anlun ^a   Xiong, Zuquan ^a   Hu, Yanxin ^a   Qi, Shijie ^a   Song, Lijun ^a   Dun, Hao ^a   Zhang, Liangyan ^b   Lou, Deyan ^b   Yang, Penghui ^b   Zhao, Zhongpeng ^b   Wang, Xiliang ^b   Zhang, Dongqing ^c   Daloze, Pierre ^d   Chen, Huifang ^a  

^a Research Centre   (Canada)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d NOTRE DAME HOSPITAL   (Canada)

Author keywords

Autoimmune disease; IL 10; MS; Nonhuman primate; Tr1; Treg

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CELL ADHESION MOLECULE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MEMBRANE COFACTOR PROTEIN; PADGEM PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; MALE; MONKEY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REMISSION; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL ADHESION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MACACA FASCICULARIS; METABOLISM; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD4; CELL ADHESION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MACACA FASCICULARIS; MULTIPLE SCLEROSIS; P-SELECTIN; SELF TOLERANCE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 63549119572     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.034     Document Type: Article

References (42)

1. Gershon R.K., Cohen P., Hencin R., and Liebhaber S.A. Suppressor T cells. J Immunol 108 (1972) 586-590
2. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6 (2005) 345-352
3. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
4. Levings M.K., Sangregorio R., Sartirana C., Moschin A.L., Battaglia M., Orban P.C., et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 196 (2002) 1335-1346
5. Bacchetta R., Sartirana C., Levings M.K., Bordignon C., Narula S., and Roncarolo M.G. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 32 (2002) 2237-2245
6. Battaglia M., Gregori S., Bacchetta R., and Roncarolo M.G. Tr1 cells: from discovery to their clinical application. Semin Immunol 18 (2006) 120-127
7. O'Garra A., and Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 10 (2004) 801-805
8. Bacchetta R., Gregori S., and Roncarolo M.G. CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 4 (2005) 491-496
9. Haas J., Fritzsching B., Trübswetter P., Korporal M., Milkova L., Fritz B., et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 179 (2007) 1322-1330
10. Wang J., Takeuchi H., Sonobe Y., Jin S., Mizuno T., Miyakawa S., et al. Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci U S A 105 (2008) 3915-3920
11. Battaglia M., Stabilini A., Draghici E., Migliavacca B., Gregori S., Bonifacio E., et al. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55 (2006) 1571-1580
12. Hafler D.A., Slavik J.M., Anderson D.E., O'Connor K.C., De Jager P., and Baecher-Allan C. Multiple sclerosis. Immunol Rev 204 (2005) 208-231
13. McQualter J.L., and Bernard C.C. Multiple sclerosis: a battle between destruction and repair. J Neurochem 100 (2007) 295-306
14. Astier A.L., and Hafler D.A. Abnormal Tr1 differentiation in multiple sclerosis. J Neuroimmunol 191 (2007) 70-78
15. Kretschmer K., Apostolou I., Jaeckel E., Khazaie K., and von Boehmer H. Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer. Immunol Rev 212 (2006) 163-169
16. Paust S., and Cantor H. Regulatory T cells and autoimmune disease. Immunol Rev 204 (2005) 195-207
17. Smith P.A., Heijmans N., Ouwerling B., Breij E.C., Evans N., van Noort J.M., et al. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. Eur J Immunol 35 (2005) 1311-1319
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
19. 't Hart B.A., Bauer J., Muller H.J., Melchers B., Nicolay K., Brok H., et al. Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). Am J Pathol 153 (1998) 649-663
20. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199 (2004) 971-979
21. Stern J.N., Keskin D.B., Zhang H., Lv H., Kato Z., and Strominger J.L. Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice. Proc Natl Acad Sci U S A 105 (2008) 5172-5176
22. Wang J., Takeuchi H., Sonobe Y., Jin S., Mizuno T., Miyakawa S., et al. Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci U S A 105 (2008) 3915-3920
23. + T cells. Clin Immunol 117 (2005) 192-199
24. + regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 57 (2008) 113-123
25. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199 (2004) 971-979
26. +CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 35 (2005) 3343-3352
27. Christen U., and von Herrath M.G. Initiation of autoimmunity. Curr Opin Immunol 16 (2004) 759-767
28. + regulatory T cells control autoimmunity. Curr Opin Immunol 17 (2005) 638-642
29. Anderson A.E., and Isaacs J.D. Tregs and rheumatoid arthritis. Acta Reumatol Port 33 (2008) 17-33
30. + T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105 (2005) 735-741
31. +CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178 (2007) 2579-2588
32. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
33. Roncarolo M., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., and Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212 (2006) 28-50
34. - Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204 (2007) 285-297
35. Dikopoulos N., Bertoletti A., Kröger A., Hauser H., Schirmbeck R., and Reimann J. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells. J Immunol 174 (2005) 99-109
36. Astier A.L. T-cell regulation by CD46 and its relevance in multiple sclerosis. Immunology 124 (2008) 149-154
37. Sanchez A., Feito M.J., and Rojo J.M. CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes. Eur J Immunol 34 (2004) 2439-2448
38. Russell S. CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function. Tissue Antigens 64 (2004) 111-118
39. Shusta E.V., Zhu C., Boado R.J., and Pardridge W.M. Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier. J Neuropathol Exp Neurol 61 (2002) 597-604
40. Astier A., Meiffren G., Freeman S., and Hafler D.A. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 116 (2006) 3252-3257
41. Sundstedt A., O'Neill E.J., Nicolson K.S., and Wraith D.C. Role for IL-10 in suppression mediated by peptideinduced regulatory T cells in vivo. J Immunol 170 (2003) 1240-1248
42. Taylor A., Verhagen J., Blaser K., Akdis M., and Akdis C.A. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells. Immunology 117 (2006) 433-442